aimed at promoting and
engaging health and wellness,
and she oversees a population
health and epidemiology
research program.
Her research interests include
World Trade Center health
effects, asbestos exposure,
occupational lung disorders
and heavy metal toxicity.
focuses on the immune
system's B cells and why B
cells sometimes become
pathogenic and cause
disease. Understanding how
to prevent the abnormal
development of pathogenic
B cells is a critical challenge
particularly given the
greater emergence of B cell
malignancy and certain
autoimmune diseases with
increased age.
develop the next generation
of human monitoring devices,
with a particular focus on
the monitoring of the injured
brain. His recent work has
focused on the development
of a "smart catheter" for
the monitoring of multiple
physiological parameters
simultaneously with a single
monitor.
on lung inflammation and
the role of the lung as an
inflammatory organ. The
studies in his lab involve both
acute and chronic disorders
that impact the lung. He is
closely studying the role
of MIF in severe sepsis and
pulmonary hypertension.
research is to understand the
causes of heart disease so
that novel therapeutics can
be developed. She studies
inflammation and neuro-
hormones during a heart
attack, and why the heart
often fails in the long term.
In the newborn patient with
congenital heart defects,
her studies address how
increased inflammation may
affect neurodevelopment.
on the regulation of immune
function and inflammation
by the nervous system. He
studies the role of brain and
peripheral neuronal pathways
in controlling cytokine
responses and inflammation,
and the therapeutic efficacy
of cholinergic modalities
in inflammatory and
obesity-driven disorders
and cancer-associated
immune dysfunction.
growing population of seniors,
Dr. Pekmezaris conducts
community-based research
investigations with seniors,
including telehealth trials for
patients living with congestive
heart failure, a randomized
trial in anemia of chronic
disease and a study to
predict site of death in end of
life patients.
research in prostate cancer,
with a focus on prostate
brachytherapy techniques
and outcomes. He also works
on systems and process
research for high-quality and
safe treatment of innovative
care and delivery models.